October 7, 2022

Patient Webinar in Recognition of Breast Cancer Awareness Month

The EndBrainCancer Initiative (EBCI) invites you to the live
patient-focused webinar:

"A Promising New Targeted Radiation Therapy for Leptomeningeal Metastases in Breast Cancer, Lung Cancer, and Other Malignancies: An Introduction"

Andrew Brenner, M.D. Ph.D. - the speaker

Professor of Medicine, Neurology, and Neurosurgery at The University of Texas Health Science Center at San Antonio and principal investigator of the ReSPECT-LM clinical trial.

This event was held on Sunday, October 9th, 2022 as part of the Musella Foundation Webinar Series. A recording of the event is available below.

Watch video

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614

DONATE

Our Case For Change

EBCI In The News

Patient Support Services

Patient Resource Center

VOLUNTEER WITH EBCI

GET IN TOUCH

corporate partners

upcoming events

resources

About us